DUSA PHARMACEUTICALS, INC. SUBSCRIPTION AGREEMENT A Minimum of 800,000 Shares ("Minimum Offering") and A Maximum of 1,500,000 Shares ("Maximum Offering") of Common Stock To: DUSA Pharmaceuticals, Inc. 181 University Avenue Suite 1208 Toronto, Ontario...Subscription Agreement • February 26th, 1999 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE OPTION AGREEMENT THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND THE COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO A REGISTRATION STATEMENT FILED WITH...Common Stock Purchase Option Agreement • February 26th, 1999 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations
EXTENSION OF WARRANT CERTIFICATE FOR PURCHASE OF COMMON STOCKWarrant Extension Agreement • February 26th, 1999 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations
September 30, 1993 Nathan A. Low, President Sunrise Financial Group, Inc. 919 Third Avenue 19th Floor New York, New York 10022 Re: Investor Relations Retainer Agreement Gentlemen: As we discussed, DUSA Pharmaceuticals, Inc. (the "Company") is...Investor Relations Retainer Agreement • February 26th, 1999 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations • New York
